Telus shares are tumbling Friday after it reported worse-than-expected Q2 results and unveiled a dividend reduction of more than half.

Teladoc Health shares slid in Thursday's premarket after Q2 results and a cautious outlook tempered its earnings outlook.

TELUS reports second quarter 2026 financial and operational results and resets quarterly dividend to support deleveraging and fuel long-term growth